Impact of preoperative NAFLD status on restoration of pancreatic β-cell function after laparoscopic sleeve gastrectomy

In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology: endocrinology and metabolism Vol. 328; no. 6; pp. E1013 - E1020
Main Authors Oe, Yuki, Nakamura, Akinobu, Cho, Kyu Yong, Takase, Takahiro, Ogawa, Koji, Ebihara, Yuma, Yoshikawa, Masato, Miya, Aika, Nomoto, Hiroshi, Kameda, Hiraku, Suda, Goki, Kudo, Kohsuke, Sakamoto, Naoya, Hirano, Satoshi, Atsumi, Tatsuya
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.06.2025
Subjects
Online AccessGet full text
ISSN0193-1849
1522-1555
1522-1555
DOI10.1152/ajpendo.00484.2024

Cover

Loading…
Abstract In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant. Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography ( r = −0.49, P < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction ( r = −0.52, P < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. NEW & NOTEWORTHY In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant.
AbstractList In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant. Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography ( r = −0.49, P < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction ( r = −0.52, P < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. NEW & NOTEWORTHY In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant.
Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this sub-analysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTT) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography (r=-0.49, P<0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction (r=-0.52, P<0.05). Neither as glycemic control nor visceral fat were significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1 year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement.Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this sub-analysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTT) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography (r=-0.49, P<0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction (r=-0.52, P<0.05). Neither as glycemic control nor visceral fat were significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1 year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement.
Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography (r = −0.49, P < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction (r = −0.52, P < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement.
Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography ( = -0.49, < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction ( = -0.52, < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant.
Author Takase, Takahiro
Kudo, Kohsuke
Nakamura, Akinobu
Kameda, Hiraku
Cho, Kyu Yong
Sakamoto, Naoya
Oe, Yuki
Ebihara, Yuma
Yoshikawa, Masato
Atsumi, Tatsuya
Ogawa, Koji
Nomoto, Hiroshi
Suda, Goki
Hirano, Satoshi
Miya, Aika
Author_xml – sequence: 1
  givenname: Yuki
  orcidid: 0000-0002-4947-5395
  surname: Oe
  fullname: Oe, Yuki
– sequence: 2
  givenname: Akinobu
  orcidid: 0000-0002-8192-0006
  surname: Nakamura
  fullname: Nakamura, Akinobu
– sequence: 3
  givenname: Kyu Yong
  surname: Cho
  fullname: Cho, Kyu Yong
– sequence: 4
  givenname: Takahiro
  surname: Takase
  fullname: Takase, Takahiro
– sequence: 5
  givenname: Koji
  surname: Ogawa
  fullname: Ogawa, Koji
– sequence: 6
  givenname: Yuma
  surname: Ebihara
  fullname: Ebihara, Yuma
– sequence: 7
  givenname: Masato
  surname: Yoshikawa
  fullname: Yoshikawa, Masato
– sequence: 8
  givenname: Aika
  surname: Miya
  fullname: Miya, Aika
– sequence: 9
  givenname: Hiroshi
  surname: Nomoto
  fullname: Nomoto, Hiroshi
– sequence: 10
  givenname: Hiraku
  surname: Kameda
  fullname: Kameda, Hiraku
– sequence: 11
  givenname: Goki
  surname: Suda
  fullname: Suda, Goki
– sequence: 12
  givenname: Kohsuke
  surname: Kudo
  fullname: Kudo, Kohsuke
– sequence: 13
  givenname: Naoya
  surname: Sakamoto
  fullname: Sakamoto, Naoya
– sequence: 14
  givenname: Satoshi
  surname: Hirano
  fullname: Hirano, Satoshi
– sequence: 15
  givenname: Tatsuya
  surname: Atsumi
  fullname: Atsumi, Tatsuya
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40376712$$D View this record in MEDLINE/PubMed
BookMark eNpdkc9O4zAQxq1V0baw-wJ7QJa4cEnx3zg5Vt3lj1TBBc6Ra49XrZI42A4rXmsfhGfCgcKB08zo-2k033zHaNb7HhD6RcmSUsku9H6A3volIaISS0aY-IYWWWAFlVLO0ILQmhe0EvUcHce4J4QoKdh3NBeEq1JRtkD_brpBm4S9w0MAP0DQafcE-HZ1ufmNY9JpjNj3OEBMftJyP7G6NwHyaPDL_8JA22I39uZN1i5BwK0edPDR-CEzsQXIS__qmAKY5LvnH-jI6TbCz0M9QQ-Xf-7X18Xm7upmvdoUhskyFVST7EUZZ0RJlKLEiK2TlbRClsxmayUllnJem6pyWjsnpLWCq63YgrVS8RN0_r53CP5xzCaabhene3UPfowNZ0QoIZkqM3r2Bd37MfT5ukwxXpeM1jJTpwdq3HZgmyHsOh2em4-XZoC9AybbjwHcJ0JJM-XWHHJr3nJrptz4K0R-jdA
Cites_doi 10.2337/diab.26.10.944
10.1001/jama.2014.5988
10.1016/j.soard.2014.06.019
10.1111/liv.12912
10.1016/j.amjmed.2009.03.015
10.1007/s00535-012-0533-z
10.1210/jc.2013-2538
10.2337/dc20-0150
10.1007/s00125-017-4513-y
10.3389/fmed.2022.894465
10.1210/jcem.85.7.6661
10.1007/BF00280883
10.2337/dc16-0382
10.1007/s00125-017-4385-1
10.14218/JCTH.2022.00085
10.1507/endocrj.k07-016
10.1038/s41598-021-83871-0
10.2337/dc08-1762
10.1002/jgh3.12367
10.1016/S0140-6736(09)60619-X
10.2337/db22-0056
10.1111/dme.13199
10.1038/s41467-021-25423-8
10.1530/EJE-12-0605
10.1210/jc.2011-0446
10.1111/j.1440-1746.1998.tb00714.x
10.2337/dc22-S002
10.1056/NEJMoa1600869
10.1210/er.2018-00183
10.2337/db22-1424-P
10.1210/clinem/dgac446
10.2337/diacare.22.9.1462
10.3389/fendo.2023.1031610
10.2337/dc17-1902
10.1016/j.cgh.2020.06.032
10.1016/j.diabres.2019.107843
10.1053/j.gastro.2016.10.026
10.1097/SLA.0b013e3182a5034b
10.1111/jdi.13221
10.1507/endocrj.EJ23-0403
10.3389/fendo.2019.00641
10.1016/j.cgh.2018.05.059
10.1002/hep.1840200104
10.1210/clinem/dgaa435
ContentType Journal Article
Copyright Copyright American Physiological Society 2025
Copyright_xml – notice: Copyright American Physiological Society 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TS
7U7
C1K
7X8
DOI 10.1152/ajpendo.00484.2024
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Physical Education Index
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Calcium & Calcified Tissue Abstracts
Physical Education Index
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
Toxicology Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1555
EndPage E1020
ExternalDocumentID 40376712
10_1152_ajpendo_00484_2024
Genre Journal Article
Observational Study
GroupedDBID ---
23M
39C
4.4
5GY
6J9
AAYXX
ABJNI
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BKOMP
BTFSW
CITATION
E3Z
EBS
EMOBN
F5P
H13
ITBOX
KQ8
OK1
P2P
P6G
PQQKQ
RAP
RHI
RPL
RPRKH
TR2
WH7
WOQ
XSW
YSK
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TS
7U7
C1K
7X8
ID FETCH-LOGICAL-c256t-1a01557cfc4607710c4bf585d4562d184610d1339c88faaff45dd437b4bedd573
ISSN 0193-1849
1522-1555
IngestDate Wed Jul 02 03:48:44 EDT 2025
Mon Jun 30 07:16:57 EDT 2025
Thu Jun 19 02:15:48 EDT 2025
Thu Jul 03 08:13:58 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords magnetic resonance imaging
nonalcoholic fatty liver disease
bariatric surgery
pancreatic beta cells
type 2 diabetes
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c256t-1a01557cfc4607710c4bf585d4562d184610d1339c88faaff45dd437b4bedd573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8192-0006
0000-0002-4947-5395
OpenAccessLink https://journals.physiology.org/doi/pdf/10.1152/ajpendo.00484.2024
PMID 40376712
PQID 3223962195
PQPubID 48583
ParticipantIDs proquest_miscellaneous_3204745276
proquest_journals_3223962195
pubmed_primary_40376712
crossref_primary_10_1152_ajpendo_00484_2024
PublicationCentury 2000
PublicationDate 2025-Jun-01
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: 2025-Jun-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
PublicationTitle American journal of physiology: endocrinology and metabolism
PublicationTitleAlternate Am J Physiol Endocrinol Metab
PublicationYear 2025
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B42
B21
B43
B22
B44
B23
B24
B25
B26
B27
B28
B29
B30
B31
B10
B32
B11
B33
B12
B34
B13
B35
B14
B36
B15
B37
B16
B38
B17
B39
B18
B19
B1
B2
B3
B4
B5
B6
B7
B8
B9
B40
B41
References_xml – ident: B18
  doi: 10.2337/diab.26.10.944
– ident: B24
  doi: 10.1001/jama.2014.5988
– ident: B26
  doi: 10.1016/j.soard.2014.06.019
– ident: B29
  doi: 10.1111/liv.12912
– ident: B3
  doi: 10.1016/j.amjmed.2009.03.015
– ident: B27
  doi: 10.1007/s00535-012-0533-z
– ident: B10
  doi: 10.1210/jc.2013-2538
– ident: B42
  doi: 10.2337/dc20-0150
– ident: B7
  doi: 10.1007/s00125-017-4513-y
– ident: B41
  doi: 10.3389/fmed.2022.894465
– ident: B15
  doi: 10.1210/jcem.85.7.6661
– ident: B17
  doi: 10.1007/BF00280883
– ident: B5
  doi: 10.2337/dc16-0382
– ident: B34
  doi: 10.1007/s00125-017-4385-1
– ident: B38
  doi: 10.14218/JCTH.2022.00085
– ident: B20
  doi: 10.1507/endocrj.k07-016
– ident: B40
  doi: 10.1038/s41598-021-83871-0
– ident: B8
  doi: 10.2337/dc08-1762
– ident: B37
  doi: 10.1002/jgh3.12367
– ident: B4
  doi: 10.1016/S0140-6736(09)60619-X
– ident: B35
  doi: 10.2337/db22-0056
– ident: B19
  doi: 10.1111/dme.13199
– ident: B13
  doi: 10.1038/s41467-021-25423-8
– ident: B31
  doi: 10.1530/EJE-12-0605
– ident: B9
  doi: 10.1210/jc.2011-0446
– ident: B36
  doi: 10.1111/j.1440-1746.1998.tb00714.x
– ident: B2
  doi: 10.2337/dc22-S002
– ident: B6
  doi: 10.1056/NEJMoa1600869
– ident: B11
  doi: 10.1210/er.2018-00183
– ident: B14
  doi: 10.2337/db22-1424-P
– ident: B22
  doi: 10.1210/clinem/dgac446
– ident: B16
  doi: 10.2337/diacare.22.9.1462
– ident: B23
  doi: 10.3389/fendo.2023.1031610
– ident: B28
  doi: 10.2337/dc17-1902
– ident: B30
  doi: 10.1016/j.cgh.2020.06.032
– ident: B1
  doi: 10.1016/j.diabres.2019.107843
– ident: B43
  doi: 10.1053/j.gastro.2016.10.026
– ident: B25
  doi: 10.1097/SLA.0b013e3182a5034b
– ident: B32
  doi: 10.1111/jdi.13221
– ident: B33
  doi: 10.1507/endocrj.EJ23-0403
– ident: B12
  doi: 10.3389/fendo.2019.00641
– ident: B44
  doi: 10.1016/j.cgh.2018.05.059
– ident: B21
  doi: 10.1002/hep.1840200104
– ident: B39
  doi: 10.1210/clinem/dgaa435
SSID ssj0007542
Score 2.4718952
Snippet In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent...
Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage E1013
SubjectTerms Adult
Bariatric Surgery
Beta cells
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - physiopathology
Diabetes Mellitus, Type 2 - surgery
Fatty liver
Female
Fibrosis
Gastrectomy
Gastrectomy - methods
Gastrointestinal surgery
Glucose
Glucose tolerance
Glucose Tolerance Test
Humans
Insulin Resistance
Insulin secretion
Insulin-Secreting Cells - metabolism
Insulin-Secreting Cells - physiology
Laparoscopy
Liver
Liver cirrhosis
Magnetic Resonance Imaging
Male
Middle Aged
Non-alcoholic Fatty Liver Disease - complications
Non-alcoholic Fatty Liver Disease - physiopathology
Non-alcoholic Fatty Liver Disease - surgery
Obesity
Obesity - complications
Obesity - surgery
Obesity, Morbid - complications
Obesity, Morbid - surgery
Observational studies
Pancreas
Preoperative Period
Prospective Studies
Proton density (concentration)
Sleeves
Steatosis
Treatment Outcome
Title Impact of preoperative NAFLD status on restoration of pancreatic β-cell function after laparoscopic sleeve gastrectomy
URI https://www.ncbi.nlm.nih.gov/pubmed/40376712
https://www.proquest.com/docview/3223962195
https://www.proquest.com/docview/3204745276
Volume 328
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCDYuhYGMxHipMprYzuVxjE6DsQmkTdqeIjtxYLRLqi4Rgp_FD-Gdf8M5dpJ6sEmMlyhNEzfN-XIun33OIeSFBpMV-lJ5CfgDHs-jzIuVX3iM60hBOJGwBPOd9w_C3SP-7lgcDwa_nFVLTa02s--X5pX8j1ThGMgVs2SvIdl-UDgA-yBf2IKEYftPMn7bpzjOF7qa67aK98HWzvs3SBLUjZkMWJjuMb1vCO-_dRWz0cb2ZON14CF7P0IL57QNn4EVxUqX1RzOO59pDQN_kphaktVdGkRXvbab9XHKUBjGxGbCYO-fMq9APZXLgk9nugb4zboChkjzGmr1pJme9gS1nMqzZmGZ3ylcrZrlagRD8e59a0YnVWt8Df8wlbZTJO59Pl1ULqsRiOXqq47oTJgH0adVp7pVzhA4g_8jXO3NgtiBqauLJ6BtmGPY4bPJu7vEagisQiu_YNfhahOVGrJtNrf7YonuP0xnv6DRhFIiSNsxUjNGimPcIDcDiGCwucbex2Uhe2w8bDP57d_s8rlE8Orv-7joM10RCBmH6PAuudNGMnTLwvIeGehylaxtlRLhQV_SDz0CVsmt_XYJxxr5akFLq4K6oKUGtNSCllYldUBrzu1BS3_-MIClHWCpASx1AUstYKkD2PvkaGdyuL3rtd0_vAzc8NrzJbrzUVZkPBxH4AhnXBUQ3OYYs-fwzMDxz33GkiyOCymLgos85yxSXOk8FxF7QFbKqtSPCOWFynGCXepQwtVRXGihY6Z8XohE6GRIRt3zTee2yEt6tUSHZL0TQdq-V-cp2EWWhGD-xZA8778GVY0PRJa6avCcMY-4CKJwSB5a0fU_x8dYVskPHl_rVp6Q28uXZ52s1ItGPwUnuVbPDNx-A_KSwaw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+preoperative+NAFLD+status+on+restoration+of+pancreatic+%CE%B2-cell+function+after+laparoscopic+sleeve+gastrectomy&rft.jtitle=American+journal+of+physiology%3A+endocrinology+and+metabolism&rft.au=Oe%2C+Yuki&rft.au=Nakamura%2C+Akinobu&rft.au=Cho%2C+Kyu+Yong&rft.au=Takase%2C+Takahiro&rft.date=2025-06-01&rft.issn=0193-1849&rft.eissn=1522-1555&rft.volume=328&rft.issue=6&rft.spage=E1013&rft.epage=E1020&rft_id=info:doi/10.1152%2Fajpendo.00484.2024&rft.externalDBID=n%2Fa&rft.externalDocID=10_1152_ajpendo_00484_2024
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1849&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1849&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1849&client=summon